BEAM
Price
$17.30
Change
-$1.18 (-6.39%)
Updated
Apr 3, 01:33 PM (EDT)
Capitalization
1.85B
40 days until earnings call
VERV
Price
$3.91
Change
-$0.23 (-5.56%)
Updated
Apr 2 closing price
Capitalization
347.19M
34 days until earnings call
Ad is loading...

BEAM vs VERV

Header iconBEAM vs VERV Comparison
Open Charts BEAM vs VERVBanner chart's image
Beam Therapeutics
Price$17.30
Change-$1.18 (-6.39%)
Volume$691
Capitalization1.85B
Verve Therapeutics
Price$3.91
Change-$0.23 (-5.56%)
Volume$2.59M
Capitalization347.19M
BEAM vs VERV Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. VERV commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and VERV is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (BEAM: $18.48 vs. VERV: $3.91)
Brand notoriety: BEAM and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 108% vs. VERV: 193%
Market capitalization -- BEAM: $1.85B vs. VERV: $347.19M
BEAM [@Biotechnology] is valued at $1.85B. VERV’s [@Biotechnology] market capitalization is $347.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileVERV’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • VERV’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEAM and VERV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while VERV’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 6 bearish.
  • VERV’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VERV is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а -15.65% price change this week, while VERV (@Biotechnology) price change was -27.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.98%. For the same industry, the average monthly price growth was -10.08%, and the average quarterly price growth was -14.19%.

Reported Earning Dates

BEAM is expected to report earnings on May 13, 2025.

VERV is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-7.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.85B) has a higher market cap than VERV($347M). BEAM YTD gains are higher at: -25.484 vs. VERV (-30.674). VERV has higher annual earnings (EBITDA): -221.91M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. VERV (524M). VERV has less debt than BEAM: VERV (70M) vs BEAM (161M). BEAM has higher revenues than VERV: BEAM (63.5M) vs VERV (32.3M).
BEAMVERVBEAM / VERV
Capitalization1.85B347M532%
EBITDA-383.98M-221.91M173%
Gain YTD-25.484-30.67483%
P/E RatioN/AN/A-
Revenue63.5M32.3M197%
Total Cash851M524M162%
Total Debt161M70M230%
TECHNICAL ANALYSIS
Technical Analysis
BEAMVERV
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 7 days ago
89%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 7 days ago
80%
Bullish Trend 10 days ago
87%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JORIX17.900.12
+0.67%
Janus Henderson Global Select S
JFEAX15.61N/A
N/A
JPMorgan Developed International Value A
JUESX23.56N/A
N/A
JPMorgan US Equity I
IJSSX14.63N/A
N/A
VY® JPMorgan Small Cap Core Equity S
TIAGX11.09N/A
N/A
Timothy Plan Small/Mid Cap Growth Cl I

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with CRSP. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
-5.44%
CRSP - VERV
54%
Loosely correlated
+3.17%
BEAM - VERV
53%
Loosely correlated
+4.79%
RXRX - VERV
50%
Loosely correlated
+3.83%
NTLA - VERV
48%
Loosely correlated
+9.69%
IVEVF - VERV
46%
Loosely correlated
N/A
More